Intrathecal injection of either Notch1 inhibitor DAPT or TLR4 inhibitor TAK ameliorated diabetic neuropathic pain behaviors, which implied that inhibition of either Notch1 signaling or TLR4 signaling alleviated painful diabetic neuropathy. The gene discussed is TLR4; the disease is diabetic neuropathy.